Evaluating the SARS-CoV-2 Specific Antibodies in Saliva
Siyang Yu1,2*, Peiyan Zhang3*, Mingfeng Liao1, Juanjuan Zhang1, Suisui Luo4, Jinglei Zhai4, Yaxi Zhang1, Jingyan Lin1, Jing Yuan3, Zheng Zhang1,5, Fuxiang Wang3, Lanlan Wei1,2
1. Institute of Hepatology, National Clinical Research Center for Infectious Disease, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China
2. Microbiology Department, Harbin Medical University, Harbin, Heilongjiang, China
3. Department of Infectious Diseases, The Third People’s Hospital of Shenzhen, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China.
4. School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
5. Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science, Shenzhen, Guangdong, China.
* These authors contributed equally to this work.